Olaparib Maintenance Reduces the Risk of Recurrence in Newly Diagnosed Patients with Advanced Ovarian Cancer Harbouring a BRCA Mutation
The benefits in patients with advanced ovarian cancer and a BRCA mutation lasted well-beyond the two-year olaparib maintenance treatment